<DOC>
<DOCNO>
EP-0000254
</DOCNO>
<TEXT>
<DATE>
19790110
</DATE>
<IPC-CLASSIFICATIONS>
C07D-417/06 C07D-295/00 C07D-417/00 C07D-275/00 A61K-31/445 <main>C07D-417/06</main> C07D-275/04 
</IPC-CLASSIFICATIONS>
<TITLE>
antithrombotic 2-(gamma-(1-piperidinyl)propyl)1,2-benzisothiazol 3-one, its pharmaceutically acceptable acid addition salts, their preparation and their compositions.
</TITLE>
<APPLICANT>
beecham group ltdgb<sep>beecham group limited<sep>beecham group plcbeecham house, great west roadbrentford, middlesex tw8 9bdgb<sep>beecham group plc <sep>
</APPLICANT>
<INVENTOR>
baggaley keith howard<sep>nunn barbara<sep>baggaley, keith howard<sep>nunn, barbara<sep>baggaley, keith howard3 blackstone hillredhill, surreygb<sep>nunn, barbara42 worcester roadsutton, surreygb<sep>baggaley, keith howard<sep>nunn, barbara  <sep>baggaley, keith howard3 blackstone hillredhill, surreygb<sep>nunn, barbara42 worcester roadsutton, surreygb<sep>
</INVENTOR>
<ABSTRACT>
2-[gamma-(1-piperidinyl) propyl]-1,2- benzisothiazol-3-one  of formula (i), or a pharmaceutically acceptable acid  addition salt thereof; their preparation and their compositions  these compounds have a high activity in inhibiting  platelet aggregation, and are therefore os use in the treatment  of arterial thrombosis.  
</ABSTRACT>
</TEXT>
</DOC>
